Choose Your News
ADMA Biologics (ADMA) has closed its public offering if ~12.9M common shares at $4 per share, including the full exercise of ~1.7M shares by underwriters. [Read More]
ADMA Biologics (ADMA) has priced its public offering of 11.25M common shares at $4.00 per share, for gross proceeds of ~$45M. Underwriters over-allotment i... [Read More]
ADMA Biologics (ADMA) slips 10% after hours in response to its planned $45M stock offering. Price, volume and terms have yet to be announced. [Read More]